MLEC
Price
$0.85Alerts
Change
-$0.55 (-39.29%)
Updated
Nov 2 closing price
Capitalization
616.73K
36 days until earnings call
Intraday BUY SELL Signals
YDES
Price
$6.15Alerts
Change
+$0.12 (+1.99%)
Updated
Nov 11 closing price
Capitalization
422.93M
Intraday BUY SELL Signals
Interact to see
Advertisement

MLEC vs YDES

MLEC vs YDES Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MLEC vs. YDES commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLEC is a Buy and YDES is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for MLEC with price predictions
Nov 10, 2026

MLEC's RSI Oscillator stays in oversold zone for 22 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MLEC just turned positive on October 27, 2026. Looking at past instances where MLEC's MACD turned positive, the stock continued to rise in 40 of 59 cases over the following month. The odds of a continued upward trend are 68%.

Following a +3.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where MLEC advanced for three days, in 102 of 145 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

MLEC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLEC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for MLEC entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.221) is normal, around the industry mean (3.498). P/E Ratio (-0.003) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.011) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. MLEC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLEC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for YDES with price predictions
Nov 10, 2026

YDES in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 22, 2026

YDES may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 14 of 22 cases where YDES's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for YDES just turned positive on November 04, 2026. Looking at past instances where YDES's MACD turned positive, the stock continued to rise in 19 of 58 cases over the following month. The odds of a continued upward trend are 33%.

YDES moved above its 50-day moving average on October 23, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +12.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where YDES advanced for three days, in 53 of 128 cases, the price rose further within the following month. The odds of a continued upward trend are 41%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 17 of 57 cases where YDES's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 30%.

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on YDES as a result. In 34 of 110 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 31%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where YDES declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

The Aroon Indicator for YDES entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. YDES’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: YDES's P/B Ratio (94.532) is slightly higher than the industry average of (3.498). YDES's P/E Ratio (1383.225) is considerably higher than the industry average of (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (212.766) is also within normal values, averaging (440.869).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. YDES’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
YDES: Fundamental Ratings
YDES
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLECYDES
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
30%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
31%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
33%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
42%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
49%
Advances
ODDS (%)
Bullish Trend 20 days ago
70%
Bullish Trend 7 days ago
41%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 21 days ago
51%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (MLEC: $0.85 vs. YDES: $6.03)
Brand notoriety: MLEC and YDES are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLEC: 152% vs. YDES: 25%
Market capitalization -- MLEC: $616.73K vs. YDES: $422.93M
MLEC [@Biotechnology] is valued at $616.73K. YDES’s [@Biotechnology] market capitalization is $422.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLEC’s FA Score shows that 1 FA rating(s) are green while YDES’s FA Score has 1 green FA rating(s).

  • MLEC’s FA Score: 1 green, 4 red.
  • YDES’s FA Score: 1 green, 4 red.
According to our system of comparison, YDES is a better buy in the long-term than MLEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLEC’s TA Score shows that 4 TA indicator(s) are bullish while YDES’s TA Score has 4 bullish TA indicator(s).

  • MLEC’s TA Score: 4 bullish, 2 bearish.
  • YDES’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MLEC is a better buy in the short-term than YDES.

Price Growth

MLEC (@Biotechnology) experienced а 0.00% price change this week, while YDES (@Biotechnology) price change was -5.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.

Reported Earning Dates

MLEC is expected to report earnings on Dec 17, 2026.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

YDES and

Correlation & Price change

A.I.dvisor indicates that over the last year, YDES has been loosely correlated with APVO. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if YDES jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YDES
1D Price
Change %
YDES100%
-10.13%
APVO - YDES
44%
Loosely correlated
-4.42%
GNPX - YDES
44%
Loosely correlated
+1.46%
MLEC - YDES
39%
Loosely correlated
N/A
CNTN - YDES
33%
Loosely correlated
-3.63%
ICU - YDES
32%
Poorly correlated
-3.06%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCRI110.170.20
+0.18%
Monarch Casino & Resort
MKTW22.29-0.09
-0.40%
MarketWise Inc
AYI331.94-2.56
-0.77%
Acuity Inc
VBIO0.53-0.01
-2.06%
Valion Bio Inc.
CERS1.95-0.12
-5.80%
Cerus Corp